Stocks Health care BIVI
NASDAQ · Health careBiovie Inc. (BIVI)
It posted a net loss of $22.1M. At June 30, 2026 it held $9M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on August 13, 2026.
Key facts about Biovie Inc.
- Net worth
- Biovie Inc. has a market value (market cap) of $10.7M at the latest share price, and shareholders' equity of $10.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2026 operations used $19M of cash.
- Latest report
- The latest periodic report (annual report, 10-K) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Biovie Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
What Biovie Inc. does
Biovie Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BIVI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | n/a | -$22.1M | -$3.05 | n/a |
| 2025 | n/a | -$17.5M | -$12.12 | n/a |
| 2024 | n/a | -$32.1M | -$73.05 | n/a |
| 2023 | n/a | -$50.3M | -$154.81 | n/a |
| 2022 | n/a | -$26.1M | -$105.87 | n/a |
| 2021 | n/a | -$130.2M | -$1,480.14 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Biovie Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 28, 2026Proxy statement DEF 14A
- September 14, 2026
- September 3, 2026Passive stake (5% or more) SCHEDULE 13G
- August 19, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026
- August 13, 2026
- August 7, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- August 6, 2026
- August 6, 2026
Insider trades
What the people running Biovie Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $49.1K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 28, 2026 | Kim Joanne WendyChief Financial Officer | Bought | 2,500 | $5.5K |
| August 28, 2026 | Chappell Amy SuzonDirector | Bought | 727 | $1.6K |
| August 28, 2026 | Palumbo Joseph MChief Medical Officer | Bought | 4,843 | $10.5K |
| August 27, 2026 | Do Cuong VPresident & CEO, Director | Bought | 15,210 | $31.6K |
Who owns BIVI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Terren S. Peizer13D, may seek influence with 1 related filers | 15.8% | June 30, 2025 |
| Alta Partners LLC13G, passive | 8.4% | August 19, 2026 |
| Jane Street Group, LLC13G, passive with 2 related filers | 5.2% | September 3, 2026 |
| DO Cuong V13D, may seek influence with 1 related filers | 5.03% | March 25, 2026 |
Largest institutional holders
Insiders
4 insiders reported holding 26,321 shares in total, about $33.4K at the last price.
| Holder | Shares |
|---|---|
| Do Cuong VPresident & CEO, Director | 16,117 |
| Palumbo Joseph MChief Medical Officer | 6,036 |
| Kim Joanne WendyChief Financial Officer | 3,441 |
| Chappell Amy SuzonDirector | 727 |
Questions about BIVI
What does Biovie Inc. do?
Biovie Inc. is a company in the Health care sector, listed on NASDAQ as BIVI. Its shares trade on NASDAQ under the ticker BIVI.
What is Biovie Inc.'s net worth?
Biovie Inc. has a market value (market cap) of $10.7M at the latest share price, and shareholders' equity of $10.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Biovie Inc. profitable?
No. In fiscal 2026 it reported a net loss of $22.1M.
When did Biovie Inc. last report?
Its most recent periodic report is the annual report (10-K) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the proxy statement from September 28, 2026.
When is Biovie Inc.'s next earnings report?
Biovie Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
Similar companies
Compare BIVI with
Follow BIVI
Get an email when Biovie Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Biovie Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.